Company
Imaging Biometrics Ltd
LON:IBAI
Since its inception, Imaging Biometrics has continued to translate the best new image analysis technologies into reliable software applications for routine clinical practice. Working in close collaboration with leading hospitals and medical researchers, the company has further improved and solidified IB Neuro as the gold standard in perfusion MR for brain tumors via stereotactic tissue correlations and outcomes measurements.
81 stories · page 3 of 5
IQ-AI notes positive outcomes from recent pediatric brain tumour studies
Inhibitory effects of oral gallium maltolate bodes well for IQ AI’s FDA application
IQ-AI brain cancer treatment granted US orphan drug status
Gallium maltolate (GaM) to treat glioblastoma multiforme (GBM) is being trialled currently for safety